# A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)

> **NCT00373529** · PHASE2 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 116 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** clofarabine

## Key facts

- **NCT ID:** NCT00373529
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-05
- **Final completion:** 2010-05
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2014-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373529, "A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00373529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*